Correlation Between Saudi Egyptian and Ibnsina Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Saudi Egyptian and Ibnsina Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Saudi Egyptian and Ibnsina Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Saudi Egyptian Investment and Ibnsina Pharma, you can compare the effects of market volatilities on Saudi Egyptian and Ibnsina Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Saudi Egyptian with a short position of Ibnsina Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Saudi Egyptian and Ibnsina Pharma.

Diversification Opportunities for Saudi Egyptian and Ibnsina Pharma

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Saudi and Ibnsina is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Saudi Egyptian Investment and Ibnsina Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ibnsina Pharma and Saudi Egyptian is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Saudi Egyptian Investment are associated (or correlated) with Ibnsina Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ibnsina Pharma has no effect on the direction of Saudi Egyptian i.e., Saudi Egyptian and Ibnsina Pharma go up and down completely randomly.

Pair Corralation between Saudi Egyptian and Ibnsina Pharma

Assuming the 90 days trading horizon Saudi Egyptian is expected to generate 2.84 times less return on investment than Ibnsina Pharma. But when comparing it to its historical volatility, Saudi Egyptian Investment is 1.14 times less risky than Ibnsina Pharma. It trades about 0.04 of its potential returns per unit of risk. Ibnsina Pharma is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  216.00  in Ibnsina Pharma on September 19, 2024 and sell it today you would earn a total of  474.00  from holding Ibnsina Pharma or generate 219.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Saudi Egyptian Investment  vs.  Ibnsina Pharma

 Performance 
       Timeline  
Saudi Egyptian Investment 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Saudi Egyptian Investment are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Saudi Egyptian is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Ibnsina Pharma 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Ibnsina Pharma are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Ibnsina Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Saudi Egyptian and Ibnsina Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Saudi Egyptian and Ibnsina Pharma

The main advantage of trading using opposite Saudi Egyptian and Ibnsina Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Saudi Egyptian position performs unexpectedly, Ibnsina Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ibnsina Pharma will offset losses from the drop in Ibnsina Pharma's long position.
The idea behind Saudi Egyptian Investment and Ibnsina Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device